Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03563248
Title Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Sibley Memorial Hospital Washington District of Columbia 20016 United States Details
The Johns Hopkins Hospital Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Boston Massachusetts 02214 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 United States Details
Brigham and Women's Hospital Boston Massachusetts 02215 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Newton Wellesley Hospital Newton Massachusetts 02462 United States Details
New York University Langone Medical Center New York New York 10016 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field